Novo Holdings A/S - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
Novo Holdings A/S ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$26,365,500
-7.0%
525,000
+17.0%
1.95%
-11.1%
Q2 2023$28,364,413
+40.5%
448,8040.0%2.19%
+64.6%
Q1 2023$20,191,692
+24.6%
448,804
+21.3%
1.33%
+31.6%
Q4 2022$16,209,700
-22.3%
370,000
+16.8%
1.01%
+1.7%
Q3 2022$20,866,000
+30.5%
316,6740.0%1.00%
+26.3%
Q2 2022$15,995,000
+10.1%
316,674
+39.2%
0.79%
+2.7%
Q1 2022$14,534,000
-31.1%
227,526
+15.5%
0.77%
-23.2%
Q4 2021$21,101,000
+4.2%
197,0000.0%1.00%
-4.7%
Q3 2021$20,254,000
+16.9%
197,0000.0%1.05%
+36.3%
Q2 2021$17,328,000
-9.5%
197,0000.0%0.77%
-2.8%
Q1 2021$19,154,000
-13.3%
197,0000.0%0.79%
-16.5%
Q4 2020$22,094,000
+1.4%
197,000
-16.2%
0.95%
-12.4%
Q3 2020$21,783,000
+8.8%
234,979
-8.5%
1.08%
-16.4%
Q2 2020$20,028,000
+46.2%
256,767
+9.6%
1.29%
+41.5%
Q1 2020$13,700,000
+0.2%
234,267
+37.3%
0.91%
+3.7%
Q4 2019$13,672,000
+9.0%
170,6670.0%0.88%
-59.0%
Q3 2019$12,539,000
-0.0%
170,667
+28.3%
2.15%
+22.3%
Q2 2019$12,544,000
+131.9%
132,976
+96.8%
1.76%
+119.6%
Q1 2019$5,409,00067,5670.80%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders